Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function

Cytokine

Volumn 50, Issue 2, 2010, Pages 152-157

  Eickmeier, Olaf ^a   Huebner, Marisa ^b   Herrmann, Eva ^c   Zissler, Ulrich ^a   Rosewich, Martin ^a   Baer, Patrick C ^c   Buhl, Roland ^b   Schmitt Grohé, Sabina ^d   Zielen, Stefan ^a   Schubert, Ralf ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITY OF BONN   (Germany)

Author keywords

Biomarkers; COPD; Cystic fibrosis; Cytometric bead array; Inflammation

Indexed keywords

AUTACOID; BIOLOGICAL MARKER; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANALYTIC METHOD; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOMETRY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL; SPUTUM ANALYSIS;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMOKINES; CYSTIC FIBROSIS; FEMALE; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SPUTUM; YOUNG ADULT;

EID: 77950866526     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.02.004     Document Type: Article

References (46)

1. Konstan M.W., Hilliard K.A., Norvell T.M., Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 1994, 150:448-454.
2. Ito K., Barnes P.J. COPD as a disease of accelerated lung aging. Chest 2009, 135:173-180.
3. Cowburn A.S., Condliffe A.M., Farahi N., Summers C., Chilvers E.R. Advances in neutrophil biology: clinical implications. Chest 2008, 134:606-612.
4. Kharitonov S.A., Barnes P.J. Biomarkers of some pulmonary diseases in exhaled breath. Biomarkers 2002, 7:1-32.
5. Knight D. Epithelium-fibroblast interactions in response to airway inflammation. Immunol Cell Biol 2001, 79:160-164.
6. Dhand R. Ventilator graphics and respiratory mechanics in the patient with obstructive lung disease. Respir Care 2005, 50:246-261. (discussion 259-261).
7. Hogg J.C. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004, 364:709-721.
8. Murin S., Hilbert J., Reilly S.J. Cigaret smoking and the lung. Clin Rev Allergy Immunol 1997, 15:307-361.
9. Aubry M.C., Wright J.L., Myers J.L. The pathology of smoking-related lung diseases. Clin Chest Med 2000, 21:11-35. vii.
10. Montnemery P., Lanke J., Lindholm L.H., Lundback B., Nyberg P., Adelroth E., et al. Familial related risk-factors in the development of chronic bronchitis/emphysema as compared to asthma assessed in a postal survey. Eur J Epidemiol 2000, 16:1003-1007.
11. Becklake M.R. Occupational exposures: evidence for a causal association with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989, 140:S85-S91.
12. Brennan S. Innate immune activation and cystic fibrosis. Paediatr Respir Rev 2008, 9:271-279. (quiz 279-280).
13. Pavord I.D., Shaw D.E., Gibson P.G., Taylor D.R. Inflammometry to assess airway diseases. Lancet 2008, 372:1017-1019.
14. Mayer-Hamblett N., Aitken M.L., Accurso F.J., Kronmal R.A., Konstan M.W., Burns J.L., et al. Association between pulmonary function and sputum biomarkers in cystic fibrosis. Am J Respir Crit Care Med 2007, 175:822-828.
15. Roy K., Smith J., Kolsum U., Borrill Z., Vestbo J., Singh D. COPD phenotype description using principal components analysis. Respir Res 2009, 10:41.
16. Schmitt-Grohe S., Eickmeier O., Schubert R., Bez C., Zielen S. Anti-inflammatory effects of montelukast in mild cystic fibrosis. Ann Allergy Asthma Immunol 2002, 89:599-605.
17. Morgan E., Varro R., Sepulveda H., Ember J.A., Apgar J., Wilson J., et al. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin Immunol 2004, 110:252-266.
18. Efthimiadis A., Spanevello A., Hamid Q., Kelly M.M., Linden M., Louis R., et al. Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J Suppl 2002, 37:19s-23s.
19. Wagner W., Roderburg C., Wein F., Diehlmann A., Frankhauser M., Schubert R., et al. Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors. Stem Cells 2007, 25:2638-2647.
20. Official statement of American Thoracic Society. Respir Care 1987, 32:1039-1060. Standardization of spirometry - 1987 update.
21. Taylor D.R., Pavord I.D. Biomarkers in the assessment and management of airways diseases. Postgrad Med J 2008, 84:628-634. (quiz 633).
22. Sagel S.D., Sontag M.K., Wagener J.S., Kapsner R.K., Osberg I., Accurso F.J. Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis. J Pediatr 2002, 141:811-817.
23. Kim J.S., Okamoto K., Rubin B.K. Pulmonary function is negatively correlated with sputum inflammatory markers and cough clearability in subjects with cystic fibrosis but not those with chronic bronchitis. Chest 2006, 129:1148-1154.
24. 1. Am J Respir Crit Care Med 1997, 155:852-857.
25. Snijders A., Van der Pouw Kraan T.C., Engel M., Wormmeester J., Widjaja P., Zonneveld I.M., Bos J.D., Kapsenberg M.L. Enhanced prostaglandin E2 production by monocytes in atopic dermatitis (AD) is not accompanied by enhanced production of IL-6, IL-10 or IL-12. Clin Exp Immunol 1998, 111:472-476.
26. Bonfield T.L., Konstan M.W., Berger M. Altered respiratory epithelial cell cytokine production in cystic fibrosis. J Allergy Clin Immunol 1999, 104:72-78.
27. Keatings V.M., Collins P.D., Scott D.M., Barnes P.J. Differences in interleukin-8 and tumor necrosis f actor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996, 153:530-534.
28. Richman-Eisenstat J.B., Jorens P.G., Hebert C.A., Ueki I., Nadel J.A. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Physiol 1993, 264:L413-L418.
29. Schmitt-Grohe S., Stuber F., Book M., Bargon J., Wagner T.O., Naujoks C., et al. TNF-alpha promoter polymorphism in relation to TNF-alpha production and clinical status in cystic fibrosis. Lung 2006, 184:99-104.
30. Schmitt-Grohe S., Naujoks C., Bargon J., Wagner T.O., Schubert R., Hippe V., et al. Interleukin-8 in whole blood and clinical status in cystic fibrosis. Cytokine 2005, 29:18-23.
31. Schmitt-Grohe S., Hippe V., Igel M., von Bergmann K., Posselt H.G., Krahl A., et al. Serum leptin and cytokines in whole blood in relation to clinical and nutritional status in cystic fibrosis. J Pediatr Gastroenterol Nutr 2006, 43:228-233.
32. Romano M., Sironi M., Toniatti C., Polentarutti N., Fruscella P., Ghezzi P., et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997, 6:315-325.
33. Kishimoto T. Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res Ther 2006, 8(Suppl. 2):S2.
34. Brightling C., Berry M., Amrani Y. Targeting TNF-alpha: a novel therapeutic approach for asthma. J Allergy Clin Immunol 2008, 121:5-10. (quiz 11-12).
35. Vroling A.B., Duinsbergen D., Fokkens W.J., van Drunen C.M. Allergen induced gene expression of airway epithelial cells shows a possible role for TNF-alpha. Allergy 2007, 62:1310-1319.
36. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 1996, 87:2095-2147.
37. Moser C., Jensen P.O., Kobayashi O., Hougen H.P., Song Z., Rygaard J., et al. N Hb. Improved outcome of chronic Pseudomonas aeruginosa lung infection is associated with induction of a Th1-dominated cytokine response. Clin Exp Immunol 2002, 127:206-213.
38. Hartl D., Griese M., Kappler M., Zissel G., Reinhardt D., Rebhan C., et al. Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis. J Allergy Clin Immunol 2006, 117:204-211.
39. Hogan S.P., Rosenberg H.F., Moqbel R., Phipps S., Foster P.S., Lacy P., et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 2008, 38:709-750.
40. Kelly M., Hwang J.M., Kubes P. Modulating leukocyte recruitment in inflammation. J Allergy Clin Immunol 2007, 120:3-10.
41. Laoukili J., Perret E., Willems T., Minty A., Parthoens E., Houcine O., et al. IL-13 alters mucociliary differentiation and ciliary beating of human respiratory epithelial cells. J Clin Invest 2001, 108:1817-1824.
42. Brennan S, Sly PD, Gangell CL, Sturges N, Winfield K, Wikstrom M et al. Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis. Eur Respir J 2009; epup.
43. Jinquan T., Jing C., Jacobi H.H., Reimert C.M., Millner A., Quan S., Hansen J.B., Dissing S., Malling H.J., Skov P.S., Poulsen L.K. CXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma. J Immunol (Baltimore, Md.: 1950) 2000, 165:1548-1556.
44. Parr D.G., White A.J., Bayley D.L., Guest P.J., Stockley R.A. Inflammation in sputum relates to progression of disease in subjects with COPD: a prospective descriptive study. Respir Res 2006, 7:136.
45. Suri R., Marshall L.J., Wallis C., Metcalfe C., Shute J.K., Bush A. Safety and use of sputum induction in children with cystic fibrosis. Pediatr Pulmonol 2003, 35:309-313.
46. Elizur A., Cannon C.L., Ferkol T.W. Airway inflammation in cystic fibrosis. Chest 2008, 133:489-495.